|

Amivantamab and Recombinant Human Hyaluronidase Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Amivantamab + Recombinant Human Hyaluronidase, Amivantamab Plus Recombinant Human Hyaluronidase, Amivantamab and Hyaluronidase, Amivantamab and Hyaluronidase-lpuj, Amivantamab with Recombinant Human Hyaluronidase +4 more

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Locally Recurrent Skin Squamous Cell Carcinoma1
  • Metastatic Skin Squamous Cell Carcinoma1
  • Cancer1

La Jolla, California1 trial

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

UC San Diego Moores Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.